Use of aerosolized tissue plasminogen activator in the treatment of plastic bronchitis

Annals of Pharmacotherapy

Volumn 47, Issue 3, 2013, Pages

  Lubcke, Nicole L ^a   Nussbaum, Vicki M ^a   Schroth, Mary ^b  

^a UW American Family Children's Hospital   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; DORNASE ALFA; FIBRIN; OXYGEN; SALBUTAMOL; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ARTICLE; ATELECTASIS; BRONCHITIS; BRONCHOSCOPY; CASE REPORT; CYANOSIS; EMERGENCY WARD; FONTAN PROCEDURE; HEMIDIAPHRAGM; HUMAN; INFLAMMATORY INFILTRATE; LOADING DRUG DOSE; LUNG EXTRAVASCULAR FLUID; MALE; MEDIASTINUM DISEASE; NEBULIZATION; OXYGEN SATURATION; OXYGEN THERAPY; PLASTIC BRONCHITIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SPIROMETRY; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADOLESCENT; AEROSOLS; BRONCHITIS; HUMANS; MALE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84875156198     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1R690     Document Type: Article

References (13)

1. Cairns-Bazarian AM, Conway EE, Yankelowitz S. Plastic bronchitis: an unusual cause of respiratory distress in children. Pediatr Emerg Care 1992;8:335-7.
2. Wakeham MK, VanBergen AH, Torero LE, Akhter J. Long-term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient. Pediatr Crit Care Med 2005;6:76-8.
3. Brogan TV, Finn LS, Pyskaty DJ, et al. Plastic bronchitis in children: a case series and review of the medical literature. Pediatr Pulmonol 2002;34:482-7.
4. Madsen P, Shah SA, Rubin BK. Plastic bronchitis: new insights and a classification scheme. Paediatr Respir Rev 2005;6:292-300.
5. Seear M, Hui F, Magee D, Cutz E. Bronchial casts in children: a proposed classification based on nine cases and a review of the literature. Am J Respir Crit Care Med 1997;155:364-70.
6. Colloridi V, Roggini M, Formiagari R, Ventriglia F, Giglioni E. Plastic bronchitis as a rare complication of Fontan's operation (letter). Pediatr Cardiol 1990;11:228.
7. Costello JM, Steinhorn D, McColley S, Gerber ME, Kumar SP. Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature. Pediatrics 2002;109: e67-9.
8. Do TB, Chu JM, Berdjis F, Anas NG. Fontan patient with plastic bronchitis treated successfully using aerosolized tissue plasminogen activator: a case report and review of the literature. Pediatr Cardiol 2009;30:352-5.
9. Heath L, Ling S, Racz J, et al. Prospective, longitudinal study of plastic bronchitis cast pathology and responsiveness to tissue plasminogen activator. Pediatr Cardiol 2011;32:1182-9.
10. Quasney MW, Orman K, Thompson J, et al. Plastic bronchitis occurring late after the Fontan procedure: treatment with aerosolized urokinase. Crit Care Med 2000;28:2107-11.
11. Lackowski NP, Pitzer JE, Tobias M, et al. Safety of prolonged, repeated administration of a pulmonary formulation of tissue plasminogen activator in mice. Pulm Pharmacol Ther 2010;23:107-14.
12. Dunn J, Nayar R, Campos J, et al. Feasibility of tissue plasminogen activator formulated for pulmonary delivery. Pharm Res 2005;22:1700-7.
13. Gibb E, Blount R, Lewis N, et al. Management of plastic bronchitis with topical tissue-type plasminogen activator. Pediatrics 2012;130:e446-e50.